1. Journal searcher
  2. Top 15 journals in Drug Discovery
  3. Molecular Therapy - Nucleic Acids
Default: Molecular Therapy - Nucleic Acids

ISSN:

Journal Home

Journal Guideline

Molecular Therapy - Nucleic Acids Q1 Unclaimed

Cell Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Therapy - Nucleic Acids is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 95. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 3285 €. The scope of the journal is focused on development of therapeutics, vector development, RNA based therapeutics, gene modifying agents, safety studies. It has an SJR impact factor of 1,849 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,849.

Molecular Therapy - Nucleic Acids focuses its scope in these topics and keywords: dna, targeting, cells, aptamer, injury, rna, kidney, expansion, engrafts, doxorubicininduced, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ Scopus WOS
Categories: Drug Discovery (Q1) Molecular Medicine (Q1)
Price

3285 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Molecular Therapy - Nucleic Acids

1,849

SJR Impact factor

95

H Index

293

Total Docs (Last Year)

975

Total Docs (3 years)

15668

Total Refs

6807

Total Cites (3 years)

944

Citable Docs (3 years)

6.26

Cites/Doc (2 years)

53.47

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1
Compare this journals

Aims and Scope

dna, targeting, cells, aptamer, injury, rna, kidney, expansion, engrafts, doxorubicininduced, disease, interconvertible, hiv, hoinduced, human, humanized, inflammationgenetic, inhibiting, discovered, crispr, agents, alphabet, anticoagulant, antisense, aptamerfunctionalized, blood, bmtwo, cancer, cardiomyocyte, cellsremoval, cerna, choroidal, contrastinduced, development of therapeutics, vector development, RNA based therapeutics, gene modifying agents, safety studies

FAQS

What is the impact factor of Molecular Therapy - Nucleic Acids?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.